Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines

Maura, FPetljak, MLionetti, MCifola, ILiang, WPinatel, EAlexandrov, L BFullam, AMartincorena, IDawson, K JAngelopoulos, NSamur, M KSzalat, RZamora, JTarpey, PDavies, HCorradini, PAnderson, K CMinvielle, SNeri, AAvet-Loiseau, HKeats, JCampbell, P JMunshi, N CBolli, N2018-05-302018Maura, F., M. Petljak, M. Lionetti, I. Cifola, W. Liang, E. Pinatel, L. B. Alexandrov, et al. 2018. “Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines.” Leukemia 32 (4): 1044-1048. doi:10.1038/leu.2017.345. http://dx.doi.org/10.1038/leu.2017.345.http://nrs.harvard.edu/urn-3:HUL.InstRepos:37067729en-USBiological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell linesJournal Article2018-05-3010.1038/leu.2017.345